ID   UTP20_HUMAN             Reviewed;        2785 AA.
AC   O75691; Q9H3H4;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 177.
DE   RecName: Full=Small subunit processome component 20 homolog;
DE   AltName: Full=Down-regulated in metastasis protein;
DE   AltName: Full=Novel nucleolar protein 73;
DE            Short=NNP73;
DE   AltName: Full=Protein Key-1A6;
GN   Name=UTP20 {ECO:0000312|HGNC:HGNC:17897}; Synonyms=DRIM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT GLN-1882.
RX   PubMed=9673349;
RA   Schwirzke M., Gnirke A., Bork P., Tarin D., Weidle U.H.;
RT   "Differential gene expression in mammary carcinoma cell lines:
RT   identification of DRIM, a new gene down-regulated in metastasis.";
RL   Anticancer Res. 18:1409-1421(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1883-2785.
RA   Ke Y., Hagiwara K., Zhao H., Ning T., Su X.L., Mcmenamin H., Lu G.R.,
RA   Wang B., Harris C.C.;
RT   "Key-1A6.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=11790298; DOI=10.1016/s0960-9822(01)00650-9;
RA   Andersen J.S., Lyon C.E., Fox A.H., Leung A.K.L., Lam Y.W., Steen H.,
RA   Mann M., Lamond A.I.;
RT   "Directed proteomic analysis of the human nucleolus.";
RL   Curr. Biol. 12:1-11(2002).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [6]
RP   INTERACTION WITH PPP1R26.
RX   PubMed=16053918; DOI=10.1016/j.bbrc.2005.06.179;
RA   Yang L., Zhao J., Lu W., Li Y., Du X., Ning T., Lu G., Ke Y.;
RT   "KIAA0649, a 1A6/DRIM-interacting protein with the oncogenic potential.";
RL   Biochem. Biophys. Res. Commun. 334:884-890(2005).
RN   [7]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 2744-LYS--LYS-2746; LYS-2744;
RP   LYS-2745; LYS-2746; 2748-LYS-LYS-2749; LYS-2748; LYS-2749; LYS-2751;
RP   LYS-2753; 2757-LYS--LYS-2760; LYS-2757; LYS-2758 AND LYS-2760.
RX   PubMed=16458307; DOI=10.1016/j.febslet.2006.01.064;
RA   Liu J., Du X., Ke Y.;
RT   "Mapping nucleolar localization sequences of 1A6/DRIM.";
RL   FEBS Lett. 580:1405-1410(2006).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH FBL.
RX   PubMed=17498821; DOI=10.1016/j.bbamcr.2007.04.002;
RA   Wang Y., Liu J., Zhao H., Lue W., Zhao J., Yang L., Li N., Du X., Ke Y.;
RT   "Human 1A6/DRIM, the homolog of yeast Utp20, functions in the 18S rRNA
RT   processing.";
RL   Biochim. Biophys. Acta 1773:863-868(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-788 AND THR-1741, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1741, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1741, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2601, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1741 AND SER-2601, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1741 AND SER-2637, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17] {ECO:0007744|PDB:7MQ8, ECO:0007744|PDB:7MQ9, ECO:0007744|PDB:7MQA}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=34516797; DOI=10.1126/science.abj5338;
RA   Singh S., Vanden Broeck A., Miller L., Chaker-Margot M., Klinge S.;
RT   "Nucleolar maturation of the human small subunit processome.";
RL   Science 373:eabj5338-eabj5338(2021).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-1645 AND PHE-2452.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Part of the small subunit (SSU) processome, first precursor
CC       of the small eukaryotic ribosomal subunit. During the assembly of the
CC       SSU processome in the nucleolus, many ribosome biogenesis factors, an
CC       RNA chaperone and ribosomal proteins associate with the nascent pre-
CC       rRNA and work in concert to generate RNA folding, modifications,
CC       rearrangements and cleavage as well as targeted degradation of pre-
CC       ribosomal RNA by the RNA exosome. Involved in 18S pre-rRNA processing.
CC       Associates with U3 snoRNA. {ECO:0000269|PubMed:17498821,
CC       ECO:0000269|PubMed:34516797}.
CC   -!- SUBUNIT: Part of the small subunit (SSU) processome, composed of more
CC       than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3
CC       (PubMed:34516797). Interacts with FBL and PPP1R26 (PubMed:16053918,
CC       PubMed:17498821). {ECO:0000269|PubMed:16053918,
CC       ECO:0000269|PubMed:17498821, ECO:0000269|PubMed:34516797}.
CC   -!- INTERACTION:
CC       O75691; Q5T8A7: PPP1R26; NbExp=4; IntAct=EBI-356062, EBI-308500;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11790298,
CC       ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:16458307,
CC       ECO:0000269|PubMed:34516797}. Note=Colocalizes with NCL in the
CC       nucleolus.
CC   -!- TISSUE SPECIFICITY: Expressed in appendix, brain, colon, fetal liver,
CC       heart, ovary, pancreas, placenta, prostate, skeletal muscle, small
CC       intestine, spleen, testis and thymus. {ECO:0000269|PubMed:9673349}.
CC   -!- SIMILARITY: Belongs to the UTP20 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG35208.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ006778; CAA07243.1; -; mRNA.
DR   EMBL; AC063948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC063951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF072718; AAG35208.1; ALT_INIT; mRNA.
DR   CCDS; CCDS9081.1; -.
DR   RefSeq; NP_055318.2; NM_014503.2.
DR   PDB; 7MQ8; EM; 3.60 A; SP=1-2785.
DR   PDB; 7MQ9; EM; 3.87 A; SP=1-2785.
DR   PDB; 7MQA; EM; 2.70 A; SP=1-2785.
DR   PDBsum; 7MQ8; -.
DR   PDBsum; 7MQ9; -.
DR   PDBsum; 7MQA; -.
DR   SMR; O75691; -.
DR   BioGRID; 118152; 200.
DR   IntAct; O75691; 24.
DR   MINT; O75691; -.
DR   STRING; 9606.ENSP00000261637; -.
DR   CarbonylDB; O75691; -.
DR   GlyGen; O75691; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75691; -.
DR   MetOSite; O75691; -.
DR   PhosphoSitePlus; O75691; -.
DR   SwissPalm; O75691; -.
DR   BioMuta; UTP20; -.
DR   SWISS-2DPAGE; O75691; -.
DR   EPD; O75691; -.
DR   jPOST; O75691; -.
DR   MassIVE; O75691; -.
DR   MaxQB; O75691; -.
DR   PaxDb; O75691; -.
DR   PeptideAtlas; O75691; -.
DR   ProteomicsDB; 50164; -.
DR   Antibodypedia; 30370; 60 antibodies from 16 providers.
DR   DNASU; 27340; -.
DR   Ensembl; ENST00000261637.5; ENSP00000261637.4; ENSG00000120800.5.
DR   GeneID; 27340; -.
DR   KEGG; hsa:27340; -.
DR   MANE-Select; ENST00000261637.5; ENSP00000261637.4; NM_014503.3; NP_055318.2.
DR   UCSC; uc001tia.2; human.
DR   AGR; HGNC:17897; -.
DR   CTD; 27340; -.
DR   DisGeNET; 27340; -.
DR   GeneCards; UTP20; -.
DR   HGNC; HGNC:17897; UTP20.
DR   HPA; ENSG00000120800; Low tissue specificity.
DR   MIM; 612822; gene.
DR   neXtProt; NX_O75691; -.
DR   OpenTargets; ENSG00000120800; -.
DR   PharmGKB; PA143485666; -.
DR   VEuPathDB; HostDB:ENSG00000120800; -.
DR   eggNOG; KOG1823; Eukaryota.
DR   GeneTree; ENSGT00390000016813; -.
DR   HOGENOM; CLU_000327_0_1_1; -.
DR   InParanoid; O75691; -.
DR   OMA; CFYMLRH; -.
DR   OrthoDB; 5482709at2759; -.
DR   PhylomeDB; O75691; -.
DR   TreeFam; TF105652; -.
DR   PathwayCommons; O75691; -.
DR   Reactome; R-HSA-6790901; rRNA modification in the nucleus and cytosol.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SignaLink; O75691; -.
DR   BioGRID-ORCS; 27340; 800 hits in 1162 CRISPR screens.
DR   ChiTaRS; UTP20; human.
DR   GeneWiki; UTP20; -.
DR   GenomeRNAi; 27340; -.
DR   Pharos; O75691; Tbio.
DR   PRO; PR:O75691; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; O75691; protein.
DR   Bgee; ENSG00000120800; Expressed in tendon of biceps brachii and 137 other tissues.
DR   Genevisible; O75691; HS.
DR   GO; GO:0030686; C:90S preribosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030688; C:preribosome, small subunit precursor; ISS:UniProtKB.
DR   GO; GO:0032040; C:small-subunit processome; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000480; P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB.
DR   GO; GO:0000447; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB.
DR   GO; GO:0000472; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0042274; P:ribosomal small subunit biogenesis; IDA:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IMP:UniProtKB.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR046523; UTP20_C.
DR   InterPro; IPR011430; UTP20_N.
DR   PANTHER; PTHR17695:SF11; SMALL SUBUNIT PROCESSOME COMPONENT 20 HOMOLOG; 1.
DR   PANTHER; PTHR17695; UNCHARACTERIZED; 1.
DR   Pfam; PF07539; DRIM; 1.
DR   Pfam; PF20416; DUF6700; 1.
DR   SUPFAM; SSF48371; ARM repeat; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; rRNA processing.
FT   CHAIN           1..2785
FT                   /note="Small subunit processome component 20 homolog"
FT                   /id="PRO_0000080011"
FT   REPEAT          165..202
FT                   /note="HEAT 1"
FT   REPEAT          1841..1878
FT                   /note="HEAT 2"
FT   REGION          880..907
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1720..1760
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          2688..2765
FT                   /evidence="ECO:0000255"
FT   MOTIF           2744..2775
FT                   /note="Nuclear localization signal"
FT   MOTIF           2744..2761
FT                   /note="Nucleolar localization signal"
FT   COMPBIAS        880..896
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         788
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         1741
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         2601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         2637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         120
FT                   /note="M -> T (in dbSNP:rs2290723)"
FT                   /id="VAR_055135"
FT   VARIANT         502
FT                   /note="S -> C (in dbSNP:rs4764643)"
FT                   /id="VAR_022162"
FT   VARIANT         1645
FT                   /note="K -> I (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs140657361)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036274"
FT   VARIANT         1882
FT                   /note="L -> Q (in dbSNP:rs10082778)"
FT                   /evidence="ECO:0000269|PubMed:9673349"
FT                   /id="VAR_055136"
FT   VARIANT         2452
FT                   /note="I -> F (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036275"
FT   VARIANT         2612
FT                   /note="E -> Q (in dbSNP:rs1061436)"
FT                   /id="VAR_022163"
FT   MUTAGEN         2744..2746
FT                   /note="KKK->AAA: Inhibits nucleolar but not nuclear
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2744
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2745
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2746
FT                   /note="K->A: Decreases nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2748..2749
FT                   /note="KK->AA: Inhibits nucleolar but not nuclear
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2748
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2749
FT                   /note="K->A: Decreases nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2751
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2753
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2757..2760
FT                   /note="KKRK->AAAA: Inhibits nucleolar localization and
FT                   decreases nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2757
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2758
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   MUTAGEN         2760
FT                   /note="K->A: Does not decrease nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:16458307"
FT   CONFLICT        1505
FT                   /note="A -> P (in Ref. 1; CAA07243)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2785 AA;  318385 MW;  0CE63611C8440E0D CRC64;
     MKTKPVSHKT ENTYRFLTFA ERLGNVNIDI IHRIDRTASY EEEVETYFFE GLLKWRELNL
     TEHFGKFYKE VIDKCQSFNQ LVYHQNEIVQ SLKTHLQVKN SFAYQPLLDL VVQLARDLQM
     DFYPHFPEFF LTITSILETQ DTELLEWAFT SLSYLYKYLW RLMVKDMSSI YSMYSTLLAH
     KKLHIRNFAA ESFTFLMRKV SDKNALFNLM FLDLDKHPEK VEGVGQLLFE MCKGVRNMFH
     SCTGQAVKLI LRKLGPVTET ETQLPWMLIG ETLKNMVKST VSYISKEHFG TFFECLQESL
     LDLHTKVTKT NCCESSEQIK RLLETYLILV KHGSGTKIPT PADVCKVLSQ TLQVASLSTS
     CWETLLDVIS ALILGENVSL PETLIKETIE KIFESRFEKR LIFSFSEVMF AMKQFEQLFL
     PSFLSYIVNC FLIDDAVVKD EALAILAKLI LNKAAPPTAG SMAIEKYPLV FSPQMVGFYI
     KQKKTRSKGR NEQFPVLDHL LSIIKLPPNK DTTYLSQSWA ALVVLPHIRP LEKEKVIPLV
     TGFIEALFMT VDKGSFGKGN LFVLCQAVNT LLSLEESSEL LHLVPVERVK NLVLTFPLEP
     SVLLLTDLYY QRLALCGCKG PLSQEALMEL FPKLQANIST GVSKIRLLTI RILNHFDVQL
     PESMEDDGLS ERQSVFAILR QAELVPATVN DYREKLLHLR KLRHDVVQTA VPDGPLQEVP
     LRYLLGMLYI NFSALWDPVI ELISSHAHEM ENKQFWKVYY EHLEKAATHA EKELQNDMTD
     EKSVGDESWE QTQEGDVGAL YHEQLALKTD CQERLDHTNF RFLLWRALTK FPERVEPRSR
     ELSPLFLRFI NNEYYPADLQ VAPTQDLRRK GKGMVAEEIE EEPAAGDDEE LEEEAVPQDE
     SSQKKKTRRA AAKQLIAHLQ VFSKFSNPRA LYLESKLYEL YLQLLLHQDQ MVQKITLDCI
     MTYKHPHVLP YRENLQRLLE DRSFKEEIVH FSISEDNAVV KTAHRADLFP ILMRILYGRM
     KNKTGSKTQG KSASGTRMAI VLRFLAGTQP EEIQIFLDLL FEPVRHFKNG ECHSAVIQAV
     EDLDLSKVLP LGRQHGILNS LEIVLKNISH LISAYLPKIL QILLCMTATV SHILDQREKI
     QLRFINPLKN LRRLGIKMVT DIFLDWESYQ FRTEEIDAVF HGAVWPQISR LGSESQYSPT
     PLLKLISIWS RNARYFPLLA KQKPGHPECD ILTNVFAILS AKNLSDATAS IVMDIVDDLL
     NLPDFEPTET VLNLLVTGCV YPGIAENIGE SITIGGRLIL PHVPAILQYL SKTTISAEKV
     KKKKNRAQVS KELGILSKIS KFMKDKEQSS VLITLLLPFL HRGNIAEDTE VDILVTVQNL
     LKHCVDPTSF LKPIAKLFSV IKNKLSRKLL CTVFETLSDF ESGLKYITDV VKLNAFDQRH
     LDDINFDVRF ETFQTITSYI KEMQIVDVNY LIPVMHNCFY NLELGDMSLS DNASMCLMSI
     IKKLAALNVT EKDYREIIHR SLLEKLRKGL KSQTESIQQD YTTILSCLIQ TFPNQLEFKD
     LVQLTHYHDP EMDFFENMKH IQIHRRARAL KKLAKQLMEG KVVLSSKSLQ NYIMPYAMTP
     IFDEKMLKHE NITTAATEII GAICKHLSWS AYMYYLKHFI HVLQTGQINQ KLGVSLLVIV
     LEAFHFDHKT LEEQMGKIEN EENAIEAIEL PEPEAMELER VDEEEKEYTC KSLSDNGQPG
     TPDPADSGGT SAKESECITK PVSFLPQNKE EIERTIKNIQ GTITGDILPR LHKCLASTTK
     REEEHKLVKS KVVNDEEVVR VPLAFAMVKL MQSLPQEVME ANLPSILLKV CALLKNRAQE
     IRDIARSTLA KIIEDLGVHF LLYVLKELQT TLVRGYQVHV LTFTVHMLLQ GLTNKLQVGD
     LDSCLDIMIE IFNHELFGAV AEEKEVKQIL SKVMEARRSK SYDSYEILGK FVGKDQVTKL
     ILPLKEILQN TTSLKLARKV HETLRRITVG LIVNQEMTAE SILLLSYGLI SENLPLLTEK
     EKNPVAPAPD PRLPPQSCLL LPPTPVRGGQ KAVVSRKTNM HIFIESGLRL LHLSLKTSKI
     KSSGECVLEM LDPFVSLLID CLGSMDVKVI TGALQCLIWV LRFPLPSIET KAEQLTKHLF
     LLLKDYAKLG AARGQNFHLV VNCFKCVTIL VKKVKSYQIT EKQLQVLLAY AEEDIYDTSR
     QATAFGLLKA ILSRKLLVPE IDEVMRKVSK LAVSAQSEPA RVQCRQVFLK YILDYPLGDK
     LRPNLEFMLA QLNYEHETGR ESTLEMIAYL FDTFPQGLLH ENCGMFFIPL CLMTINDDSA
     TCKKMASMTI KSLLGKISLE KKDWLFDMVT TWFGAKKRLN RQLAALICGL FVESEGVDFE
     KRLGTVLPVI EKEIDPENFK DIMEETEEKA ADRLLFSFLT LITKLIKECN IIQFTKPAET
     LSKIWSHVHS HLRHPHNWVW LTAAQIFGLL FASCQPEELI QKWNTKKTKK HLPEPVAIKF
     LASDLDQKMK SISLASCHQL HSKFLDQSLG EQVVKNLLFA AKVLYLLELY CEDKQSKIKE
     DLEEQEALED GVACADEKAE SDGEEKEEVK EELGRPATLL WLIQKLSRIA KLEAAYSPRN
     PLKRTCIFKF LGAVAMDLGI DKVKPYLPMI IAPLFRELNS TYSEQDPLLK NLSQEIIELL
     KKLVGLESFS LAFASVQKQA NEKRALRKKR KALEFVTNPD IAAKKKMKKH KNKSEAKKRK
     IEFLRPGYKA KRQKSHSLKD LAMVE
//
